TrialLancet (London, England)2016

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.

Sally Wenzel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.